It is an ester-derived prodrug that is converted in vivo by serum and tissue esterases to tenofovir, an acyclic nucleoside phosphonate (nucleotide) that inhibits HIV reverse transcriptase.
Sequence variations in human immunodeficiency virus (HIV)-1 reverse transcriptase (RT) and protease, the molecular targets of anti-retroviral drug therapy, are prime examples of genes in which ...
1). It belongs to the class of nucleoside reverse transcriptase inhibitors (NRTIs), which have been at the forefront of antiretroviral therapy ever since. Figure 1: Timeline of the development of ...
The four main classes, which most people are treated with, target one of three viral proteins which control HIV’s lifecycle: reverse transcriptase, integrase and protease. Historically, most people ...
More than 46,000 of them had been prescribed a form of HIV-suppressing medications known as reverse transcriptase (RT) inhibitors. Among this subgroup, Alzheimer's diagnoses occurred in about 2.5 ...
They use an enzyme called reverse transcriptase, just like the human immunodeficiency virus (HIV), to replicate themselves. Humans have evolved mechanisms to keep retrotransposons turned off most ...
The new data – presented at the IDWeek congress yesterday – found that the pairing of MSD's experimental nucleoside reverse transcriptase translocation inhibitor islatravir with Gilead's ...